Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 22 |
NetGPI | no | yes: 0, no: 22 |
Term | Name | Level | Count |
---|---|---|---|
GO:0031019 | mitochondrial mRNA editing complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0045293 | mRNA editing complex | 3 | 1 |
GO:0098798 | mitochondrial protein-containing complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
Related structures:
AlphaFold database: Q6T452
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 23 |
GO:0003824 | catalytic activity | 1 | 23 |
GO:0003972 | RNA ligase (ATP) activity | 5 | 23 |
GO:0005488 | binding | 1 | 23 |
GO:0005524 | ATP binding | 5 | 23 |
GO:0008452 | RNA ligase activity | 4 | 23 |
GO:0016874 | ligase activity | 2 | 23 |
GO:0016886 | ligase activity, forming phosphoric ester bonds | 3 | 23 |
GO:0017076 | purine nucleotide binding | 4 | 23 |
GO:0030554 | adenyl nucleotide binding | 5 | 23 |
GO:0032553 | ribonucleotide binding | 3 | 23 |
GO:0032555 | purine ribonucleotide binding | 4 | 23 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 23 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 23 |
GO:0036094 | small molecule binding | 2 | 23 |
GO:0043167 | ion binding | 2 | 23 |
GO:0043168 | anion binding | 3 | 23 |
GO:0097159 | organic cyclic compound binding | 2 | 23 |
GO:0097367 | carbohydrate derivative binding | 2 | 23 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 23 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 23 |
GO:1901265 | nucleoside phosphate binding | 3 | 23 |
GO:1901363 | heterocyclic compound binding | 2 | 23 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.524 |
CLV_NRD_NRD_1 | 141 | 143 | PF00675 | 0.300 |
CLV_NRD_NRD_1 | 178 | 180 | PF00675 | 0.197 |
CLV_NRD_NRD_1 | 255 | 257 | PF00675 | 0.364 |
CLV_NRD_NRD_1 | 283 | 285 | PF00675 | 0.491 |
CLV_NRD_NRD_1 | 296 | 298 | PF00675 | 0.324 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.519 |
CLV_NRD_NRD_1 | 38 | 40 | PF00675 | 0.403 |
CLV_NRD_NRD_1 | 385 | 387 | PF00675 | 0.338 |
CLV_NRD_NRD_1 | 396 | 398 | PF00675 | 0.327 |
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.524 |
CLV_PCSK_KEX2_1 | 140 | 142 | PF00082 | 0.363 |
CLV_PCSK_KEX2_1 | 255 | 257 | PF00082 | 0.296 |
CLV_PCSK_KEX2_1 | 283 | 285 | PF00082 | 0.511 |
CLV_PCSK_KEX2_1 | 296 | 298 | PF00082 | 0.321 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.532 |
CLV_PCSK_KEX2_1 | 38 | 40 | PF00082 | 0.389 |
CLV_PCSK_KEX2_1 | 385 | 387 | PF00082 | 0.333 |
CLV_PCSK_KEX2_1 | 79 | 81 | PF00082 | 0.272 |
CLV_PCSK_PC1ET2_1 | 140 | 142 | PF00082 | 0.363 |
CLV_PCSK_PC1ET2_1 | 79 | 81 | PF00082 | 0.285 |
CLV_PCSK_SKI1_1 | 102 | 106 | PF00082 | 0.387 |
CLV_PCSK_SKI1_1 | 108 | 112 | PF00082 | 0.288 |
CLV_PCSK_SKI1_1 | 152 | 156 | PF00082 | 0.381 |
CLV_PCSK_SKI1_1 | 22 | 26 | PF00082 | 0.587 |
CLV_PCSK_SKI1_1 | 264 | 268 | PF00082 | 0.350 |
CLV_PCSK_SKI1_1 | 363 | 367 | PF00082 | 0.262 |
CLV_PCSK_SKI1_1 | 4 | 8 | PF00082 | 0.690 |
CLV_Separin_Metazoa | 387 | 391 | PF03568 | 0.502 |
DEG_APCC_DBOX_1 | 211 | 219 | PF00400 | 0.357 |
DEG_APCC_DBOX_1 | 3 | 11 | PF00400 | 0.689 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.520 |
DOC_CKS1_1 | 378 | 383 | PF01111 | 0.379 |
DOC_CYCLIN_RxL_1 | 1 | 8 | PF00134 | 0.432 |
DOC_CYCLIN_RxL_1 | 102 | 113 | PF00134 | 0.402 |
DOC_CYCLIN_RxL_1 | 9 | 21 | PF00134 | 0.375 |
DOC_MAPK_gen_1 | 140 | 147 | PF00069 | 0.280 |
DOC_MAPK_gen_1 | 296 | 302 | PF00069 | 0.448 |
DOC_MAPK_gen_1 | 9 | 18 | PF00069 | 0.534 |
DOC_PP1_RVXF_1 | 388 | 395 | PF00149 | 0.356 |
DOC_USP7_MATH_1 | 78 | 82 | PF00917 | 0.287 |
DOC_USP7_MATH_2 | 346 | 352 | PF00917 | 0.243 |
DOC_USP7_UBL2_3 | 363 | 367 | PF12436 | 0.260 |
DOC_WW_Pin1_4 | 115 | 120 | PF00397 | 0.357 |
DOC_WW_Pin1_4 | 350 | 355 | PF00397 | 0.294 |
DOC_WW_Pin1_4 | 377 | 382 | PF00397 | 0.353 |
LIG_14-3-3_CanoR_1 | 12 | 16 | PF00244 | 0.559 |
LIG_14-3-3_CanoR_1 | 179 | 186 | PF00244 | 0.243 |
LIG_14-3-3_CanoR_1 | 334 | 339 | PF00244 | 0.368 |
LIG_APCC_ABBA_1 | 15 | 20 | PF00400 | 0.512 |
LIG_BIR_III_4 | 262 | 266 | PF00653 | 0.214 |
LIG_FHA_1 | 110 | 116 | PF00498 | 0.303 |
LIG_FHA_1 | 119 | 125 | PF00498 | 0.261 |
LIG_FHA_1 | 378 | 384 | PF00498 | 0.385 |
LIG_FHA_1 | 54 | 60 | PF00498 | 0.264 |
LIG_FHA_1 | 6 | 12 | PF00498 | 0.641 |
LIG_FHA_2 | 179 | 185 | PF00498 | 0.383 |
LIG_FHA_2 | 351 | 357 | PF00498 | 0.290 |
LIG_LIR_Gen_1 | 183 | 194 | PF02991 | 0.256 |
LIG_LIR_Gen_1 | 27 | 35 | PF02991 | 0.355 |
LIG_LIR_Gen_1 | 274 | 282 | PF02991 | 0.416 |
LIG_LIR_LC3C_4 | 247 | 251 | PF02991 | 0.264 |
LIG_LIR_Nem_3 | 168 | 174 | PF02991 | 0.311 |
LIG_LIR_Nem_3 | 23 | 29 | PF02991 | 0.384 |
LIG_LIR_Nem_3 | 274 | 279 | PF02991 | 0.397 |
LIG_LIR_Nem_3 | 402 | 407 | PF02991 | 0.393 |
LIG_LIR_Nem_3 | 88 | 93 | PF02991 | 0.270 |
LIG_NRBOX | 356 | 362 | PF00104 | 0.251 |
LIG_Pex14_2 | 49 | 53 | PF04695 | 0.320 |
LIG_PTB_Apo_2 | 156 | 163 | PF02174 | 0.351 |
LIG_SH2_CRK | 93 | 97 | PF00017 | 0.267 |
LIG_SH2_NCK_1 | 133 | 137 | PF00017 | 0.264 |
LIG_SH2_NCK_1 | 29 | 33 | PF00017 | 0.405 |
LIG_SH2_SRC | 133 | 136 | PF00017 | 0.280 |
LIG_SH2_STAP1 | 172 | 176 | PF00017 | 0.264 |
LIG_SH2_STAP1 | 191 | 195 | PF00017 | 0.205 |
LIG_SH2_STAP1 | 206 | 210 | PF00017 | 0.231 |
LIG_SH2_STAP1 | 87 | 91 | PF00017 | 0.199 |
LIG_SH2_STAT3 | 103 | 106 | PF00017 | 0.387 |
LIG_SH2_STAT5 | 165 | 168 | PF00017 | 0.434 |
LIG_SH2_STAT5 | 186 | 189 | PF00017 | 0.350 |
LIG_SH2_STAT5 | 391 | 394 | PF00017 | 0.303 |
LIG_SH2_STAT5 | 399 | 402 | PF00017 | 0.339 |
LIG_SH3_1 | 133 | 139 | PF00018 | 0.274 |
LIG_SH3_2 | 136 | 141 | PF14604 | 0.402 |
LIG_SH3_3 | 133 | 139 | PF00018 | 0.274 |
LIG_SH3_3 | 302 | 308 | PF00018 | 0.390 |
LIG_SH3_3 | 375 | 381 | PF00018 | 0.257 |
LIG_TRAF2_1 | 181 | 184 | PF00917 | 0.402 |
LIG_TRAF2_1 | 275 | 278 | PF00917 | 0.379 |
LIG_TRAF2_1 | 291 | 294 | PF00917 | 0.383 |
LIG_UBA3_1 | 96 | 105 | PF00899 | 0.214 |
MOD_CK1_1 | 118 | 124 | PF00069 | 0.362 |
MOD_CK1_1 | 337 | 343 | PF00069 | 0.371 |
MOD_CK2_1 | 178 | 184 | PF00069 | 0.300 |
MOD_CK2_1 | 27 | 33 | PF00069 | 0.395 |
MOD_CK2_1 | 350 | 356 | PF00069 | 0.402 |
MOD_GlcNHglycan | 201 | 204 | PF01048 | 0.214 |
MOD_GlcNHglycan | 302 | 305 | PF01048 | 0.387 |
MOD_GlcNHglycan | 80 | 83 | PF01048 | 0.262 |
MOD_GSK3_1 | 296 | 303 | PF00069 | 0.410 |
MOD_GSK3_1 | 337 | 344 | PF00069 | 0.279 |
MOD_GSK3_1 | 346 | 353 | PF00069 | 0.282 |
MOD_NEK2_1 | 226 | 231 | PF00069 | 0.269 |
MOD_NEK2_1 | 271 | 276 | PF00069 | 0.342 |
MOD_PIKK_1 | 346 | 352 | PF00454 | 0.344 |
MOD_PK_1 | 296 | 302 | PF00069 | 0.365 |
MOD_PK_1 | 334 | 340 | PF00069 | 0.363 |
MOD_PKA_1 | 296 | 302 | PF00069 | 0.381 |
MOD_PKA_2 | 11 | 17 | PF00069 | 0.525 |
MOD_PKA_2 | 178 | 184 | PF00069 | 0.243 |
MOD_PKA_2 | 27 | 33 | PF00069 | 0.371 |
MOD_PKA_2 | 296 | 302 | PF00069 | 0.372 |
MOD_PKB_1 | 150 | 158 | PF00069 | 0.243 |
MOD_Plk_1 | 355 | 361 | PF00069 | 0.311 |
MOD_Plk_2-3 | 27 | 33 | PF00069 | 0.371 |
MOD_Plk_4 | 118 | 124 | PF00069 | 0.281 |
MOD_Plk_4 | 264 | 270 | PF00069 | 0.279 |
MOD_Plk_4 | 309 | 315 | PF00069 | 0.377 |
MOD_Plk_4 | 334 | 340 | PF00069 | 0.357 |
MOD_Plk_4 | 356 | 362 | PF00069 | 0.240 |
MOD_ProDKin_1 | 115 | 121 | PF00069 | 0.357 |
MOD_ProDKin_1 | 350 | 356 | PF00069 | 0.294 |
MOD_ProDKin_1 | 377 | 383 | PF00069 | 0.349 |
MOD_SUMO_rev_2 | 14 | 24 | PF00179 | 0.398 |
MOD_SUMO_rev_2 | 258 | 266 | PF00179 | 0.415 |
MOD_SUMO_rev_2 | 368 | 378 | PF00179 | 0.402 |
TRG_DiLeu_BaEn_1 | 356 | 361 | PF01217 | 0.408 |
TRG_DiLeu_BaLyEn_6 | 322 | 327 | PF01217 | 0.156 |
TRG_DiLeu_BaLyEn_6 | 378 | 383 | PF01217 | 0.472 |
TRG_ENDOCYTIC_2 | 186 | 189 | PF00928 | 0.249 |
TRG_ENDOCYTIC_2 | 29 | 32 | PF00928 | 0.379 |
TRG_ENDOCYTIC_2 | 391 | 394 | PF00928 | 0.294 |
TRG_ENDOCYTIC_2 | 87 | 90 | PF00928 | 0.278 |
TRG_ENDOCYTIC_2 | 93 | 96 | PF00928 | 0.258 |
TRG_ER_diArg_1 | 11 | 13 | PF00400 | 0.554 |
TRG_ER_diArg_1 | 2 | 4 | PF00400 | 0.534 |
TRG_ER_diArg_1 | 295 | 297 | PF00400 | 0.351 |
TRG_ER_diArg_1 | 38 | 40 | PF00400 | 0.406 |
TRG_ER_diArg_1 | 384 | 386 | PF00400 | 0.424 |
TRG_NLS_MonoExtN_4 | 139 | 144 | PF00514 | 0.424 |
TRG_Pf-PMV_PEXEL_1 | 108 | 113 | PF00026 | 0.243 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HTX0 | Leptomonas seymouri | 75% | 100% |
A0A0N1IKD9 | Leptomonas seymouri | 42% | 81% |
A0A0S4IH84 | Bodo saltans | 41% | 85% |
A0A0S4JRM1 | Bodo saltans | 58% | 82% |
A0A1X0NW43 | Trypanosomatidae | 69% | 100% |
A0A1X0P2V9 | Trypanosomatidae | 41% | 90% |
A0A3R7NWI2 | Trypanosoma rangeli | 69% | 100% |
A0A3S5H791 | Leishmania donovani | 96% | 100% |
A0A422NFE4 | Trypanosoma rangeli | 42% | 91% |
A0A451EJB4 | Leishmania donovani | 39% | 99% |
A4H382 | Leishmania braziliensis | 39% | 99% |
A4HRI2 | Leishmania infantum | 39% | 99% |
A4HZ02 | Leishmania infantum | 97% | 100% |
C9ZIM1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 66% | 100% |
C9ZXL1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 89% |
E9AC50 | Leishmania major | 40% | 100% |
E9AIM1 | Leishmania braziliensis | 88% | 100% |
E9AJE6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 39% | 100% |
E9AUV4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
P32277 | Enterobacteria phage T4 | 26% | 100% |
P86924 | Trypanosoma brucei brucei | 66% | 100% |
P86925 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 66% | 100% |
P86926 | Trypanosoma brucei brucei | 41% | 89% |
P86927 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 41% | 89% |
V5ASZ3 | Trypanosoma cruzi | 68% | 100% |
V5DD75 | Trypanosoma cruzi | 42% | 84% |